Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · June 10, 2021

Real-Time vs Intermittent Glucose Monitoring in Type 1 Diabetes

The Lancet


Additional Info

Disclosure statements are available on the authors' profiles:

The Lancet
Comparing Real-Time and Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes (ALERTT1): A 6-Month, Prospective, Multicentre, Randomised Controlled Trial
Lancet 2021 Jun 12;397(10291)2275-2283, MM Visser, S Charleer, S Fieuws, C De Block, R Hilbrands, L Van Huffel, T Maes, G Vanhaverbeke, E Dirinck, N Myngheer, C Vercammen, F Nobels, B Keymeulen, C Mathieu, P Gillard

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading